扬子江药业集团江苏制药股份有限公司 Reviews

Note: How fast is hiring at 扬子江药业集团江苏制药股份有限公司 growing? 2025年28个（持平），2024年28个（增长17%），2023年24个（增长71%），2022年14个（下降42%），2021年24个. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

— What Are the Salaries Like? (29 records)

Manage

Salary Overview

￥6-10K

82.7% of roles pay

salary range: 4.5K - 15K, 82.7% of roles pay ￥6-10K

13.8% 4.5-6K ***  ? 6-8K ***  ? 8-10K 3.4% 10-15K

Note: salary statistics are based on 29 salary records from the past year and depend on the job sample. For reference only.

Salary Ranking

By Category

技工类￥6.8K  质量管理类  工厂生产类  人力资源类  生物/制药/化工/环保类 

扬子江药业集团江苏制药股份有限公司工资待遇怎么样？82.7%的岗位拿6-10K，本科工资￥。泰州地区工资排名第263，与同行业比-31%，技工类平均工资￥6.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)

Are salaries high at 扬子江药业集团江苏制药股份有限公司? We provide: qa，培训，技工，qc，技术工程师，操作工，普工，管培生，质量，验证专员，ra，临床，会计，储备干部，化验，发展专员，工艺员，技术人员，招聘专员，班长. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

技工类
27.6% of total 27.6%
质量管理类
24.1% of total 24.1%
工厂生产类
20.7% of total 20.7%
人力资源类
13.8% of total 13.8%

Job Location

泰州
100% of total 100%

Education

本科
55.2% of total 55.2%
大专
27.6% of total 27.6%
高中
17.2% of total 17.2%

Experience

不限
55.2% of total 55.2%
1-3年
44.8% of total 44.8%

View Detailed Analysis

What does 扬子江药业集团江苏制药股份有限公司 require? Who is 扬子江药业集团江苏制药股份有限公司 hiring? 招聘类别技工类占比最多占27.6%，其次是质量管理类占24.1%。什么学历能进？本科占比最多占55.2%，其次是大专占27.6%。工作经验有什么要求？不限占比最多占55.2%，其次是1-3年占44.8%。工作地区在哪？泰州占比最多占100%。 Based on job postings from the past year, for reference only.